JP2022504392A5 - - Google Patents
Info
- Publication number
- JP2022504392A5 JP2022504392A5 JP2021518891A JP2021518891A JP2022504392A5 JP 2022504392 A5 JP2022504392 A5 JP 2022504392A5 JP 2021518891 A JP2021518891 A JP 2021518891A JP 2021518891 A JP2021518891 A JP 2021518891A JP 2022504392 A5 JP2022504392 A5 JP 2022504392A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody fragment
- human
- domain
- met antibody
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102018000009282 | 2018-10-09 | ||
| IT102018000009282A IT201800009282A1 (it) | 2018-10-09 | 2018-10-09 | Nuovo agente terapeutico per il trattamento di un tumore e/o metastasi |
| PCT/EP2019/077116 WO2020074459A1 (en) | 2018-10-09 | 2019-10-07 | Anti-met fab-fc for the treatment of a tumor and/or metastasis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022504392A JP2022504392A (ja) | 2022-01-13 |
| JP2022504392A5 true JP2022504392A5 (enExample) | 2022-05-12 |
| JP7371093B2 JP7371093B2 (ja) | 2023-10-30 |
Family
ID=65010823
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021518891A Active JP7371093B2 (ja) | 2018-10-09 | 2019-10-07 | 腫瘍および／または転移の治療のための抗－ｍｅｔ ｆａｂ－ｆｃ |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US12209129B2 (enExample) |
| EP (2) | EP3864050B1 (enExample) |
| JP (1) | JP7371093B2 (enExample) |
| KR (2) | KR20250078600A (enExample) |
| CN (2) | CN119587692A (enExample) |
| AU (2) | AU2019358417B2 (enExample) |
| CA (1) | CA3115582A1 (enExample) |
| CY (1) | CY1125831T1 (enExample) |
| DK (1) | DK3864050T5 (enExample) |
| ES (1) | ES2938714T3 (enExample) |
| FI (1) | FI3864050T3 (enExample) |
| HR (1) | HRP20230154T1 (enExample) |
| HU (1) | HUE060843T2 (enExample) |
| IL (1) | IL282033B2 (enExample) |
| IT (1) | IT201800009282A1 (enExample) |
| LT (1) | LT3864050T (enExample) |
| PL (1) | PL3864050T3 (enExample) |
| PT (1) | PT3864050T (enExample) |
| RS (1) | RS63960B1 (enExample) |
| SG (1) | SG11202103575RA (enExample) |
| SI (1) | SI3864050T1 (enExample) |
| SM (1) | SMT202300053T1 (enExample) |
| WO (1) | WO2020074459A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121443643A (zh) | 2023-06-01 | 2026-01-30 | 皮埃尔法布雷医药公司 | 基于沉默抗体的抗met构建体用于治疗肿瘤和转移 |
| WO2026087699A1 (en) | 2024-10-24 | 2026-04-30 | Pierre Fabre Medicament | New treatment of non-small cell lung cancer |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1718677E (pt) | 2003-12-19 | 2012-07-18 | Genentech Inc | Fragmentos de anticorpo monovalentes úteis como agentes terapêuticos |
| ES2368864T3 (es) | 2006-02-06 | 2011-11-23 | Metheresis Translational Research Sa | Anticuerpos monoclonales anti-met, sus fragmentos y vectores para el tratamiento de tumores y productos correspondientes. |
| CA2650822C (en) * | 2006-04-28 | 2017-03-14 | Esbatech Ag | Antibodies binding to the extracellular domain of the receptor tyrosine kinase alk |
| KR101837053B1 (ko) * | 2008-10-01 | 2018-03-12 | 암젠 리서치 (뮌헨) 게엠베하 | 종간 특이적 ＰＳＣＡｘＣＤ３, ＣＤ19ｘＣＤ3, ｃ-ＭＥＴｘＣＤ3, 엔도시알린ｘＣＤ3, ＥｐＣＡＭｘＣＤ3, ＩＧＦ-1ＲｘＣＤ3 또는 ＦＡＰαｘＣＤ3 이중특이적 단일쇄 항체 |
| JP5734201B2 (ja) * | 2008-12-19 | 2015-06-17 | マクロジェニクス，インコーポレーテッド | 共有結合型ダイアボディ及びその使用 |
| PE20120877A1 (es) * | 2009-04-01 | 2012-08-06 | Genentech Inc | ANTICUERPOS ANTI-FcRH5 E INMUNOCONJUGADOS |
| EP2500036B1 (en) * | 2011-03-18 | 2014-05-07 | Metheresis Translational Research SA | MET inhibitors for enhancing radiotherapy efficacy |
| ES2785081T3 (es) * | 2011-04-01 | 2020-10-05 | Memorial Sloan Kettering Cancer Center | Anticuerpos biespecíficos similares a receptores de células T específicos para un péptido de WT1 presentado por HLA-A2 |
| WO2013033008A2 (en) * | 2011-08-26 | 2013-03-07 | Merrimack Pharmaceuticals, Inc. | Tandem fc bispecific antibodies |
| SG11201402485UA (en) | 2011-11-21 | 2014-06-27 | Genentech Inc | Purification of anti-c-met antibodies |
| ITTO20130012A1 (it) * | 2013-01-09 | 2014-07-10 | Metheresis Translational Res S A | Nuovi frammenti anticorpali, relative composizioni ed usi |
| GB201403875D0 (en) * | 2014-03-05 | 2014-04-16 | Cantargia Ab | Novel antibodies and uses thereof |
| EP3571221A2 (en) * | 2017-01-20 | 2019-11-27 | Juno Therapeutics GmbH | Cell surface conjugates and related cell compositions and methods |
-
2018
- 2018-10-09 IT IT102018000009282A patent/IT201800009282A1/it unknown
-
2019
- 2019-10-07 KR KR1020257016475A patent/KR20250078600A/ko active Pending
- 2019-10-07 PT PT198086753T patent/PT3864050T/pt unknown
- 2019-10-07 JP JP2021518891A patent/JP7371093B2/ja active Active
- 2019-10-07 DK DK19808675.3T patent/DK3864050T5/da active
- 2019-10-07 ES ES19808675T patent/ES2938714T3/es active Active
- 2019-10-07 RS RS20230107A patent/RS63960B1/sr unknown
- 2019-10-07 EP EP19808675.3A patent/EP3864050B1/en active Active
- 2019-10-07 KR KR1020217013513A patent/KR102814490B1/ko active Active
- 2019-10-07 PL PL19808675.3T patent/PL3864050T3/pl unknown
- 2019-10-07 CA CA3115582A patent/CA3115582A1/en active Pending
- 2019-10-07 FI FIEP19808675.3T patent/FI3864050T3/fi active
- 2019-10-07 HU HUE19808675A patent/HUE060843T2/hu unknown
- 2019-10-07 EP EP22206743.1A patent/EP4194469A1/en active Pending
- 2019-10-07 WO PCT/EP2019/077116 patent/WO2020074459A1/en not_active Ceased
- 2019-10-07 CN CN202411779087.7A patent/CN119587692A/zh active Pending
- 2019-10-07 HR HRP20230154TT patent/HRP20230154T1/hr unknown
- 2019-10-07 SI SI201930456T patent/SI3864050T1/sl unknown
- 2019-10-07 SG SG11202103575RA patent/SG11202103575RA/en unknown
- 2019-10-07 IL IL282033A patent/IL282033B2/en unknown
- 2019-10-07 CN CN201980080611.2A patent/CN113330032B/zh active Active
- 2019-10-07 LT LTEPPCT/EP2019/077116T patent/LT3864050T/lt unknown
- 2019-10-07 US US17/283,482 patent/US12209129B2/en active Active
- 2019-10-07 AU AU2019358417A patent/AU2019358417B2/en active Active
- 2019-10-07 SM SM20230053T patent/SMT202300053T1/it unknown
-
2023
- 2023-02-09 CY CY20231100073T patent/CY1125831T1/el unknown
-
2024
- 2024-12-09 US US18/973,463 patent/US20250101115A1/en active Pending
-
2026
- 2026-02-26 AU AU2026201438A patent/AU2026201438A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN115057936B (zh) | 异源二聚体多特异性抗体形式 | |
| NZ717476A (en) | Anti-garp protein and uses thereof | |
| DK2921503T3 (en) | Human antibody to human epidermal growth factor receptor and coding gene and its use | |
| EA032681B1 (ru) | ГЕТЕРОДИМЕР Fc ИММУНОГЛОБУЛИНА, СОДЕРЖАЩИЙ ВАРИАНТ ДОМЕНА CH3 ДЛЯ ОБРАЗОВАНИЯ АНТИТЕЛА ИЛИ ГИБРИДНОГО БЕЛКА С ГЕТЕРОМЕРНЫМ Fc С ВЫСОКОЙ ЭФФЕКТИВНОСТЬЮ, СПОСОБ ДЛЯ ЕГО ПОЛУЧЕНИЯ И ИСПОЛЬЗОВАНИЯ | |
| JP7792044B2 (ja) | ヒト化抗ｉｌ－１ｒ３抗体及び使用方法 | |
| JP7657591B2 (ja) | 二重特異性抗原結合コンストラクト | |
| JP2020536512A (ja) | タンパク性ヘテロ二量体及びその使用 | |
| JP2023514371A (ja) | 操作された抗ｈｅｒ２二重特異性タンパク質 | |
| KR20230157933A (ko) | 감마-델타 t 세포 수용체에 결합하는 항체 | |
| WO2020015687A1 (zh) | 抗her3人源化单克隆抗体及其制剂 | |
| CN117120478A (zh) | 一种抗原结合分子 | |
| WO2024046301A1 (zh) | 包含taci多肽的融合蛋白及其用途 | |
| US20260109781A1 (en) | Anti-her2 antibodies and methods of use thereof | |
| WO2024017281A1 (zh) | 多特异性抗体及其用途 | |
| WO2020192648A1 (en) | Proteinaceous heterodimer and use thereof | |
| WO2023174238A9 (zh) | 特异性结合gprc5d和cd3的抗原结合分子及其医药用途 | |
| FI3864050T3 (fi) | Anti-met-fab-fc kasvaimen ja/tai metastaasin hoitamiseksi | |
| JP2021518170A5 (enExample) | ||
| WO2025140701A1 (zh) | 抗egfr单抗、其双特异性抗体、药物组合物和用途 | |
| HK40110414A (en) | Anti-her2 antibodies and methods of use thereof | |
| JP2024534824A (ja) | 操作された抗ｈｅｒ２二重特異性タンパク質 | |
| US20230391892A1 (en) | Bifunctional antagonists of tumor necrosis factor alpha and transforming growth factor beta and uses thereof | |
| HK40084724A (en) | Engineered anti-her2 bispecific proteins | |
| WO2024188319A1 (zh) | 抗muc17、cd3和cd28三特异性抗体 | |
| WO2024131849A1 (zh) | Cd38单克隆抗体及其应用 |